Issue navigation
Volume 22, Issue 4, 1 April 2016
Original Article
Respective Roles of Hematopoietic and Nonhematopoietic Nod2 on the Gut Microbiota and Mucosal Homeostasis
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 763–773, https://doi.org/10.1097/MIB.0000000000000749
Ulcerative Colitis Is Under Dual (Mitochondrial and Nuclear) Genetic Control
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 774–781, https://doi.org/10.1097/MIB.0000000000000694
Ulcerative Colitis-Associated Long Noncoding RNA, BC012900, Regulates Intestinal Epithelial Cell Apoptosis
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 782–795, https://doi.org/10.1097/MIB.0000000000000691
HLA-C*01 is a Risk Factor for Crohn's Disease
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 796–806, https://doi.org/10.1097/MIB.0000000000000693
Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 807–816, https://doi.org/10.1097/MIB.0000000000000674
Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 817–825, https://doi.org/10.1097/MIB.0000000000000684
Identification of Commensal Species Positively Correlated with Early Stress Responses to a Compromised Mucus Barrier
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 826–840, https://doi.org/10.1097/MIB.0000000000000688
Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 841–852, https://doi.org/10.1097/MIB.0000000000000699
Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 853–861, https://doi.org/10.1097/MIB.0000000000000696
Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 862–869, https://doi.org/10.1097/MIB.0000000000000705
Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 870–879, https://doi.org/10.1097/MIB.0000000000000679
Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 880–885, https://doi.org/10.1097/MIB.0000000000000754
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 886–893, https://doi.org/10.1097/MIB.0000000000000715
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 894–901, https://doi.org/10.1097/MIB.0000000000000757
Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 902–911, https://doi.org/10.1097/MIB.0000000000000710
Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 912–918, https://doi.org/10.1097/MIB.0000000000000675
Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 919–924, https://doi.org/10.1097/MIB.0000000000000753
Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 925–932, https://doi.org/10.1097/MIB.0000000000000700
Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis: A Meta-analysis of Controlled Clinical Trials
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 933–939, https://doi.org/10.1097/MIB.0000000000000680
Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 940–947, https://doi.org/10.1097/MIB.0000000000000740
Impact of Concurrent Non-IBD Immunological Diseases on the Outcome of Primary Sclerosing Cholangitis
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 948–954, https://doi.org/10.1097/MIB.0000000000000690
Development and Validation of the Short Crohn's Disease Work Disability Questionnaire
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 955–962, https://doi.org/10.1097/MIB.0000000000000678
Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 963–967, https://doi.org/10.1097/MIB.0000000000000686
Editorial
Editorial
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Page 968, https://doi.org/10.1097/MIB.0000000000000711
Future Directions and Methods for IBD Researchs
Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 969–975, https://doi.org/10.1097/MIB.0000000000000709
Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 976–983, https://doi.org/10.1097/MIB.0000000000000756
Basic Science Review Article
Epithelial ER Stress in Crohn's Disease and Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 984–993, https://doi.org/10.1097/MIB.0000000000000660
Clinical Review Article
Biosimilars in Crohn's Disease and Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 994–997, https://doi.org/10.1097/MIB.0000000000000673
How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 998–1009, https://doi.org/10.1097/MIB.0000000000000661
How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 1010–1019, https://doi.org/10.1097/MIB.0000000000000649
Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 1020–1025, https://doi.org/10.1097/MIB.0000000000000666
